Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q2 2024 · 10-Q
Revenue$4.38M$4.38M−29.9% vs Q2 2023 Net Income-$3.01M-$3.01MN/M vs Q2 2023 EPS Diluted-$1.35-$1.35N/M vs Q2 2023 Gross Profit$2,580,728−35.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$704,068N/M Free Cash Flowderived-$699,448N/M Margins · derivedGross margin59.0%−5.4 pt vs Q2 2023
Operating margin-35.4%−13.0 pt vs Q2 2023
Net margin-68.8%−47.4 pt vs Q2 2023
ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end